Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Broadstone Net Lease Announces Second Quarter 2024 Results

In This Article:

VICTOR, N.Y., July 30, 2024--(BUSINESS WIRE)--Broadstone Net Lease, Inc. (NYSE: BNL) ("BNL", the "Company", "we", "our", or "us"), today announced its operating results for the quarter ended June 30, 2024.

MANAGEMENT COMMENTARY

"We are performing well in all facets of our business, and I am incredibly proud of our results and execution on our strategic priorities through the first half of this year," said John Moragne, BNL’s Chief Executive Officer. "We had ambitious goals for 2024 and are well on our way to meeting them. We are on the cusp of substantially completing our healthcare portfolio simplification strategy, having fully redeployed those proceeds into closed and committed investments, and are continuing to build a strong pipeline focused on our differentiated core building blocks of growth, seeing incremental revenue generating capital expenditures with our existing tenants and build-to-suit funding opportunities with our development partners that supplement our traditional net lease acquisition pipeline. Combined with a solid and streamlined portfolio with top tier weighted average annual rent growth, a fortified balance sheet with low leverage and ample liquidity, and the benefits of prudent and disciplined capital decisions, we are positioning BNL to generate attractive and sustainable growth in 2025 and beyond."

SECOND QUARTER 2024 HIGHLIGHTS

INVESTMENT
ACTIVITY

  • During the second quarter, we invested $247.8 million, including $165.1 million in new property acquisitions, $52.2 million in transitional capital, and $30.5 million in development fundings. The new property acquisitions had a weighted average initial cash capitalization rate of 7.3%, a weighted average lease term of 11.5 years, and weighted average annual rent increases of 2.3%. Total investments consist of $134.3 million in industrial properties and $113.5 million in retail and restaurant properties.

  • Through the second quarter, we have invested $287.9 million, including $165.1 million in new property acquisitions, $52.2 million in transitional capital, $67.7 million in development fundings, and $3.0 million in revenue generating capital expenditures. The revenue generating capital expenditures had a weighted average initial cash capitalization rate of 8.0%, a lease term of 8.0 years, and annual rent increase of 2.5%. Total investments consist of $171.4 million in industrial properties, $113.5 million in retail and restaurant properties, and $3.0 million in animal health services properties.

  • Subsequent to quarter-end, we invested $11.3 million in development fundings.

  • As of the date of this release, we have an additional $69.3 million of acquisitions under control and $339.3 million of commitments to fund developments. Our commitments to fund developments were sourced through existing and new developer relationships, and include $331.7 million of industrial properties and $7.6 million of restaurant properties with varying construction start dates through 2024 and rent commencement dates beginning throughout 2025 and the first half of 2026.

  • During the second quarter, we sold three properties for gross proceeds of $24.4 million at a weighted average cash capitalization rate of 7.3%. Together with dispositions from the first quarter and subsequent to quarter end, we have sold 45 properties for gross proceeds of $306.9 million at a weighted average cash capitalization rate of 7.8% on tenanted properties. The dispositions included 5 properties for gross proceeds of $30.8 million relating to our previously announced Portfolio Sale (as discussed below) as part of our healthcare portfolio simplification strategy.

OPERATING
R
ESULTS

  • Generated net income of $35.9 million, or $0.19 per share.

  • Generated adjusted funds from operations ("AFFO") of $70.4 million, or $0.36 per share.

  • Incurred $9.9 million of general and administrative expenses, inclusive of $2.1 million of stock-based compensation.

  • Portfolio was 99.3% leased based on rentable square footage, with only three of our 777 properties vacant and not subject to a lease at quarter end.

  • Collected 99.0% of base rents due for the second quarter for all properties under lease. Excluding rents from Green Valley Medical Center, rent collections were 99.8%.

 

CAPITAL
MARKETS
ACTIVITY

  • Ended the quarter with total outstanding debt of $1.9 billion, Net Debt of $1.9 billion, a Net Debt to Annualized Adjusted EBITDAre ratio of 5.1x, and a Pro Forma Net Debt to Annualized Adjusted EBITDAre ratio of 4.9x.

  • At June 30, 2024, had $920.9 million of capacity on our unsecured revolving credit facility.

  • In May 2024, we refreshed our ATM Program, increasing the available capacity to $400.0 million.

  • In June 2024, we entered into $460.0 million of forward interest rate swaps starting in 2025 and maturing through 2030 at a weighted average fixed rate of 3.73%.

  • Declared a quarterly dividend of $0.29.

 

SUMMARIZED FINANCIAL RESULTS

 

 

For the Three Months Ended

 

 

For the Six Months Ended

 

(in thousands, except per share data)

 

June 30,
2024

 

 

March 31,
2024

 

 

June 30,
2023

 

 

June 30,
2024

 

 

June 30,
2023

 

Revenues

 

$

105,907

 

 

$

105,366

 

 

$

109,353

 

 

$

211,274

 

 

$

228,345

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income, including non-controlling interests

 

$

35,937

 

 

$

68,177

 

 

$

62,996

 

 

$

104,114

 

 

$

104,370

 

Net earnings per share – diluted

 

$

0.19

 

 

$

0.35

 

 

$

0.32

 

 

$

0.53

 

 

$

0.53

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FFO

 

$

73,725

 

 

$

73,135

 

 

$

72,524

 

 

$

146,861

 

 

$

153,701

 

FFO per share

 

$

0.37

 

 

$

0.37

 

 

$

0.37

 

 

$

0.74

 

 

$

0.78

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Core FFO

 

$

73,001

 

 

$

74,072

 

 

$

74,381

 

 

$

147,073

 

 

$

148,854

 

Core FFO per share

 

$

0.37

 

 

$

0.38

 

 

$

0.38

 

 

$

0.74

 

 

$

0.76

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AFFO

 

$

70,401

 

 

$

70,873

 

 

$

69,004

 

 

$

141,276

 

 

$

136,489

 

AFFO per share

 

$

0.36

 

 

$

0.36

 

 

$

0.35

 

 

$

0.72

 

 

$

0.69

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted Weighted Average Shares Outstanding

 

 

196,470

 

 

 

196,417

 

 

 

196,228

 

 

 

196,379

 

 

 

196,148

 

FFO, Core FFO, and AFFO are measures that are not calculated in accordance with accounting principles generally accepted in the United States of America ("GAAP"). See the Reconciliation of Non-GAAP Measures later in this press release.